354112-08-6

Basic information

• Product Name: N,N-DIBOC-4-AMINO-6-CHLOROPYRIMIDINE
• Synonyms: N,N-DIBOC-4-AMINO-6-CHLOROPYRIMIDINE;6-[bis(tert-butoxycarbonyl)amino]-4-chloropyrimidine;Di-tert-butyl (6-chloropyrimidin-4-yl)imidodicarbonate;tert-Butyl N-tert-butoxycarbonyl-N-(6-chloropyrimidin-4-yl)carbamate
• CAS NO: 354112-08-6
• Molecular Formula: C14H20ClN3O4
• Molecular Weight: 329.79
• Product Categories: Heterocycle-Pyrimidine series
• Mol File: 354112-08-6.mol
• Article Data: 8

Chemical Properties

• Boiling Point: 407.3 °C at 760 mmHg
• Flash Point: 200.1 °C
• Appearance: /
• Density: 1.244 g/cm³
• Vapor Pressure: 7.64E-07mmHg at 25°C
• Refractive Index: 1.532
• Storage Temp.: under inert gas (nitrogen or Argon) at 2-8°C
• CAS DataBase Reference: N,N-DIBOC-4-AMINO-6-CHLOROPYRIMIDINE(CAS DataBase Reference)
• NIST Chemistry Reference: N,N-DIBOC-4-AMINO-6-CHLOROPYRIMIDINE(354112-08-6)
• EPA Substance Registry System: N,N-DIBOC-4-AMINO-6-CHLOROPYRIMIDINE(354112-08-6)

Safety Data

• Hazardous Substances Data: 354112-08-6(Hazardous Substances Data)

Usage

General Description

N,N-DIBOC-4-AMINO-6-CHLOROPYRIMIDINE is a chemical compound used in organic synthesis and pharmaceutical research. It is a derivative of pyrimidine, a heterocyclic organic compound commonly found in nucleic acids such as DNA and RNA. The compound is often used as a building block in the synthesis of various pharmaceuticals and agrochemicals. Its chemical structure contains a chloropyrimidine moiety, which makes it a valuable intermediate in the production of drugs and other biologically active molecules. Additionally, it is also used as a reagent in organic chemistry reactions for the creation of new compounds with potential pharmacological and agricultural applications.

InChI:InChI=1/C14H20ClN3O4/c1-13(2,3)21-11(19)18(12(20)22-14(4,5)6)10-7-9(15)16-8-17-10/h7-8H,1-6H3

Upstream product

• 5305-59-9 4-amino-6-chloropyrimidine 
• 24424-99-5 di-tert-butyl dicarbonate 

Relevant articles and documents

Structure-based Design of Pyridone-Aminal eFT508 Targeting Dysregulated Translation by Selective Mitogen-activated Protein Kinase Interacting Kinases 1 and 2 (MNK1/2) Inhibition

Dysregulated translation of mRNA plays a major role in tumorigenesis. Mitogen-activated protein kinase interacting kinases (MNK)1/2 are key regulators of mRNA translation integrating signals from oncogenic and immune signaling pathways through phosphoryla

ANTI-ANGIOGENESIS COMPOUND, INTERMEDIATE AND USE THEREOF

Disclosed are an anti-abnormal proliferation of angiogenesis compound represented by formula I, use and intermediate thereof. The compound has good effect against abnormal proliferation of angiogenesis, and the activity of the compound is produced by inhibiting VEGFR2. The compound can be used for treating diseases, such as wet macular degeneration, inflammation, malignant tumor and the like, caused by abnormity of angiogenesis and protein kinases such as VEGFR2, FGFR2 and the like.

Α 7 as intranuclear hydroxynicotinic acetylcholine receptor quinuclidines compd.

PROBLEM TO BE SOLVED: To provide ligands for the nicotinic α-7 receptor used for the treatment of various disorders of the central nervous system, especially affective and neurodegenerative disorders.SOLUTION: The disclosure provides compounds of the specified formula I, including their salts, and compositions and methods using the compounds.